Virax Biolabs Group Limited (VRAX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.2
Day's range
$0.22

Virax Biolabs Group Ltd Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
XTX TOPCO LTD 02/17/2026 21.44 K $7.41 K   100.00% 0.45%
UBS GROUP AG 01/29/2026 7.49 K $2.59 K   122.98% 0.16%
NATIONAL BANK OF CANADA /FI/ 02/17/2026 6.00 K $2.07 K   -40.00% 0.13%
ADVISOR GROUP HOLDINGS, INC. 02/17/2026 20 $7   100.00% 0.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 02/10/2026 10 $3   100.00% 0.00%
HRT FINANCIAL LP 02/12/2026 0 $0   -100.00% 0.00%
VIRTU FINANCIAL LLC 02/23/2026 0 $0   -100.00% 0.00%

Virax Biolabs Group Ltd institutional Ownership - FAQ's

During the previous two years, 7 institutional investors and hedge funds held shares of Virax Biolabs Group Ltd. The most heavily invested institutionals were:

UBS Group AG: 0

XTX Topco Ltd: 21,437

NATIONAL BANK OF CANADA /FI/: 6,000

ADVISOR GROUP HOLDINGS, INC.: 20

NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO: 10

Virtu Financial LLC: 0

0.73% of Virax Biolabs Group Ltd stock is owned by institutional investors.

Institutional investors have bought a total of 27.47 K shares in the last 24 months. This purchase volume represents approximately $5.49 K in transactions.